ATAllison Thibodeau

Allison Thibodeau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Allison Thibodeau has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Yield of a multiplexed gastrointestinal polymerase chain reaction panel for evaluation of diarrhea in hospitalized patients with cancer: a diagnostic stewardship opportunity

    by Emily A. Rosen, Shandra Truong, Elizabeth M. Krantz, Allison Thibodeau, Cynthia K. Wallace, Zahra Kassamali Escobar, Pooja Bhattacharyya, Regina Lengermann, Michelle Swetky, Salma Walji, et al.

    Background: Multiplexed polymerase chain reaction gastrointestinal panels (GIPs) include mostly community-acquired pathogens. Diagnostic yield of GIPs for detection of non- Clostridioides difficile targets in hospitalized patients with cancer with community versus hospital-onset diarrhea is not well defined. Methods: This cross-sectional study included stool tests from hospitalized adults with a cancer diagnosis from July 2021 to May 2025. Our center recommends a GIP primarily for patients with community-onset diarrhea and stand-alone C. difficile testing for hospital-onset diarrhea. Generalized estimating equations with Poisson regression were used to estimate the prevalence ratio (PR) of detecting ≥1 non- C. difficile target after hospital day (HD) 3 compared to HD 1–3. Results: Among 1,433 GIPs from 1,127 patients, 468 (33%) were ordered after HD 3. Most GIPs were among patients with hematologic malignancies (794/1,433; 55%) and of those tests 352/794 (44%) were ordered after HD 3. Among all GIPs, C. difficile and norovirus were detected most frequently (16% and 6%, respectively). A non- C. difficile target was detected after HD 3 on 49/468 GIPs (10%), compared to 146/965 (15%) GIPs on HD 1–3 (adjusted PR 0.73; 95% CI [0.53–1.00]; P = .053). Among 49 GIPs after HD 3 detecting ≥1 non- C. difficile target, 19 tests were ordered for new-onset diarrhea and only 5 of these patients received intentional antimicrobial therapy in response to the GIP result. Conclusions: The added diagnostic yield for detecting ≥1 non- C. difficile target by GIP in patients with cancer and hospital-onset diarrhea is limited and supports restricting GIP ordering after HD 3 on oncology units.

  • Open Access

    Diagnostic Yield of Repeat Blood Cultures and Risk Factors for Bloodstream Infection in Persistent Febrile Neutropenia

    by Emily A Rosen, Elizabeth M Krantz, Allison Thibodeau, Keara Kennedy, Leah H Yoke, Frank Tverdek, Zahra Kassamali Escobar, Jason P Cooper, Masumi Ueda Oshima, Paul Hendrie, et al.

    Background: The optimal frequency of repeat blood cultures in persistent febrile neutropenia (FN) remains unknown. This study aimed to identify opportunities for blood culture diagnostic stewardship in persistent FN. Methods: This was a retrospective cohort study of patients with hematology/oncology diagnoses and an FN episode lasting >3 days. Generalized estimating equation logistic regression models were used to evaluate risk factors for new bloodstream infection (BSI) after FN day 3. Results: Among 620 patients, the median FN duration was 5 days, with a median of 12 blood culture bottles collected per patient. On FN day 1, 25% of patients had a positive blood culture; on FN days 2–9, <5% of patients per day had a new organism isolated. Among 31 new organisms isolated after FN day 3, 8 (26%) were contaminants. Of 503 patients with ≥1 blood culture collected after FN day 3, 19 (4%) had a new BSI after FN day 3. FN onset in the peri–hematopoietic cell transplant period (from day −7 to day +30) was associated with lower odds of new BSI after FN day 3 (odds ratio, 0.18 [95% confidence interval, .04–.71]; P = .01). Thirty-six patients died within 30 days after FN day 3, including 4 with a new BSI after FN day 3; 1 death was attributable to BSI after FN day 3. Conclusions: Detection of new BSIs after FN day 3 was uncommon, demonstrating the low diagnostic yield of repeat blood cultures after FN day 3. FN episodes in the peri–hematopoietic cell transplant period may be a potential focus for blood culture diagnostic stewardship initiatives.